Last reviewed · How we verify
NCT06594003
Motor Sparing Techniques, Genicular Nerve Radiofrequency Ablation Has Emerged As a Viable Alternative to Conservative Therapy and Total Knee Arthroplasty
NA trial testing Radiofrequency in Knee Osteoarthritis \(OA\) in 60 participants. Not yet recruiting.
1 October 2025
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 October 2024 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 November 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Radiofrequency — full drug profile →
Conditions studied
- Knee Osteoarthritis \(OA\) — all drugs for Knee Osteoarthritis \(OA\) →
Sponsor
Assiut University
Who can join
Adults 50 to 70, any sex, with Knee Osteoarthritis \(OA\). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There has recently been considerable interest in the role of radiofrequency ablation (RFA) of the genicular nerves for KOA. In the majority of previous studies, ablation was done via a radiofrequency technique using either fluoroscopy or ultrasound for only three genicular nerves, whereas the knee joint is also supplied by a few other nerves (11, 12). Interestingly, neurolytic agents can also be used to ablate the nerves, and are readily available, less costly, and need less logistic support
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06594003
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Radiofrequency
Trials testing the same drug.
- NCT07279142 — Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder · NA · not yet recruiting
- NCT07213050 — Percutaneous Thermal Ablation (Radiofrequency and Microwave) in the Treatment of Anterior Abdominal Wall Masses: An Eval · NA · not yet recruiting
- NCT07131943 — Radiofrequency vs. Ultrasound Therapy for Shoulder Joint in Stroke Patients: A Comparative Clinical Trial · NA · recruiting
- NCT07097532 — Cutaneous Silent Period-Based Comparison of DRG-PRF and TFESI in Lumbar Radicular Pain · NA · active not recruiting
- NCT06755099 — Female Sexual Dysfunction Assessment and Managment of Vaginismus · Phase 2, PHASE3 · not yet recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06594003 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06594003.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing